Clinical trial
PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer
NCT03304210
Study timeline
Study start (actual)2017-09-16Date precision: day
Registry last updated2023-11-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Peritoneal Carcinomatosisunresolved
Ovarian Cancer Stage IIIBunresolved
Ovarian Cancer Stage IIICunresolved
Ovarian Cancer Stage IVunresolved
Breast Cancer Stage IIIBunresolved
Breast Cancer Stage IIIcunresolved
Breast Cancer Stage IVunresolved
Stomach Cancer Stage IIIunresolved
Stomach Cancer Stage IV With Metastasesunresolved
Pancreas Cancer, Stage IIIunresolved
Pancreas Cancer, Stage IVunresolved
Interventions
Sponsors & collaborators
University Hospital, Ghentlead sponsor
Kom Op Tegen Kankercollaborator
University Ghentcollaborator
Hopital Lariboisièrecollaborator
University Women's Hospital Tübingencollaborator
Candiolo Cancer Institute - IRCCScollaborator
Centre Hospitalier Universitaire Vaudoiscollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03304210 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.